A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1

Salvatore J. Siciliano, Shawn E. Kuhmann, Youmin Weng, Navid Madani, Martin S. Springer, Janet E. Lineberger, Renee Danzeisen, Michael D. Miller, Michael P. Kavanaugh, Julie A. DeMartino, David Kabat

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Like the CCR5 chemokine receptors of humans and rhesus macaques, the very homologous (~98-99% identical) CCR5 of African green monkeys (AGMs) avidly binds β-chemokines and functions as a coreceptor for simian immunodeficiency viruses. However, AGM CCR5 is a weak coreceptor for tested macrophage-tropic (R5) isolates of human immunodeficiency virus type 1 (HIV- 1). Correspondingly, gp120 envelope glycoproteins derived from R5 isolates of HIV-1 bind poorly to AGM CCR5. We focused on a unique extracellular amino acid substitution at the juncture of transmembrane helix 4 (TM4) and extracellular loop 2 (ECL2) (Arg for Gly at amino acid 163 (G163R)) as the likely source of the weak R5 gp120 binding and HIV-1 coreceptor properties of AGM CCRS. Accordingly, a G163R mutant of human CCR5 was severely attenuated in its ability to bind R5 gp120s and to mediate infection by R5 HIV-1 isolates. Conversely, the R163G mutant of AGM CCR5 was substantially strengthened as a coreceptor for HIV-1 and had improved R5 gp120 binding affinity relative to the wild-type AGM CCR5. These substitutions at amino acid position 163 had no effect on chemokine binding or signal transduction, suggesting the absence of structural alterations. The 2D7 monoclonal antibody has been reported to bind to ECL2 and to block HIV-1 binding and infection. Whereas 2D7 antibody binding to CCR5 was unaffected by the G163R mutation, it was prevented by a conservative ECL2 substitution (K171R), shared between rhesus and AGM CCR5s. Thus, it appears that the 2D7 antibody binds to an epitope that includes Lys-171 and may block HIV-1 infection mediated by CCR5 by occluding an HIV-1-binding site in the vicinity of Gly163. In summary, our results identify a site for gp120 interaction that is critical for R5 isolates of HIV-1 in the central core of human CCR5, and we propose that this site collaborates with a previously identified region in the CCR5 amino terminus to enable gp120 binding and HIV-1 infections.

Original languageEnglish (US)
Pages (from-to)1905-1913
Number of pages9
JournalJournal of Biological Chemistry
Volume274
Issue number4
DOIs
StatePublished - Jan 22 1999

Fingerprint

CCR5 Receptors
Chemokine Receptors
Viruses
Cercopithecus aethiops
HIV-1
Substitution reactions
Chemokines
Amino Acids
Tropics
Signal transduction
Antibodies
Macrophages
HIV Envelope Protein gp120
Epitopes
Glycoproteins
HIV Infections
Binding Sites
Monoclonal Antibodies
Amino Acid Substitution
Simian Immunodeficiency Virus

ASJC Scopus subject areas

  • Biochemistry

Cite this

Siciliano, S. J., Kuhmann, S. E., Weng, Y., Madani, N., Springer, M. S., Lineberger, J. E., ... Kabat, D. (1999). A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. Journal of Biological Chemistry, 274(4), 1905-1913. https://doi.org/10.1074/jbc.274.4.1905

A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. / Siciliano, Salvatore J.; Kuhmann, Shawn E.; Weng, Youmin; Madani, Navid; Springer, Martin S.; Lineberger, Janet E.; Danzeisen, Renee; Miller, Michael D.; Kavanaugh, Michael P.; DeMartino, Julie A.; Kabat, David.

In: Journal of Biological Chemistry, Vol. 274, No. 4, 22.01.1999, p. 1905-1913.

Research output: Contribution to journalArticle

Siciliano, SJ, Kuhmann, SE, Weng, Y, Madani, N, Springer, MS, Lineberger, JE, Danzeisen, R, Miller, MD, Kavanaugh, MP, DeMartino, JA & Kabat, D 1999, 'A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1', Journal of Biological Chemistry, vol. 274, no. 4, pp. 1905-1913. https://doi.org/10.1074/jbc.274.4.1905
Siciliano, Salvatore J. ; Kuhmann, Shawn E. ; Weng, Youmin ; Madani, Navid ; Springer, Martin S. ; Lineberger, Janet E. ; Danzeisen, Renee ; Miller, Michael D. ; Kavanaugh, Michael P. ; DeMartino, Julie A. ; Kabat, David. / A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. In: Journal of Biological Chemistry. 1999 ; Vol. 274, No. 4. pp. 1905-1913.
@article{8a6b4bb9b7ce4d18bf1551b11c1cd953,
title = "A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1",
abstract = "Like the CCR5 chemokine receptors of humans and rhesus macaques, the very homologous (~98-99{\%} identical) CCR5 of African green monkeys (AGMs) avidly binds β-chemokines and functions as a coreceptor for simian immunodeficiency viruses. However, AGM CCR5 is a weak coreceptor for tested macrophage-tropic (R5) isolates of human immunodeficiency virus type 1 (HIV- 1). Correspondingly, gp120 envelope glycoproteins derived from R5 isolates of HIV-1 bind poorly to AGM CCR5. We focused on a unique extracellular amino acid substitution at the juncture of transmembrane helix 4 (TM4) and extracellular loop 2 (ECL2) (Arg for Gly at amino acid 163 (G163R)) as the likely source of the weak R5 gp120 binding and HIV-1 coreceptor properties of AGM CCRS. Accordingly, a G163R mutant of human CCR5 was severely attenuated in its ability to bind R5 gp120s and to mediate infection by R5 HIV-1 isolates. Conversely, the R163G mutant of AGM CCR5 was substantially strengthened as a coreceptor for HIV-1 and had improved R5 gp120 binding affinity relative to the wild-type AGM CCR5. These substitutions at amino acid position 163 had no effect on chemokine binding or signal transduction, suggesting the absence of structural alterations. The 2D7 monoclonal antibody has been reported to bind to ECL2 and to block HIV-1 binding and infection. Whereas 2D7 antibody binding to CCR5 was unaffected by the G163R mutation, it was prevented by a conservative ECL2 substitution (K171R), shared between rhesus and AGM CCR5s. Thus, it appears that the 2D7 antibody binds to an epitope that includes Lys-171 and may block HIV-1 infection mediated by CCR5 by occluding an HIV-1-binding site in the vicinity of Gly163. In summary, our results identify a site for gp120 interaction that is critical for R5 isolates of HIV-1 in the central core of human CCR5, and we propose that this site collaborates with a previously identified region in the CCR5 amino terminus to enable gp120 binding and HIV-1 infections.",
author = "Siciliano, {Salvatore J.} and Kuhmann, {Shawn E.} and Youmin Weng and Navid Madani and Springer, {Martin S.} and Lineberger, {Janet E.} and Renee Danzeisen and Miller, {Michael D.} and Kavanaugh, {Michael P.} and DeMartino, {Julie A.} and David Kabat",
year = "1999",
month = "1",
day = "22",
doi = "10.1074/jbc.274.4.1905",
language = "English (US)",
volume = "274",
pages = "1905--1913",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1

AU - Siciliano, Salvatore J.

AU - Kuhmann, Shawn E.

AU - Weng, Youmin

AU - Madani, Navid

AU - Springer, Martin S.

AU - Lineberger, Janet E.

AU - Danzeisen, Renee

AU - Miller, Michael D.

AU - Kavanaugh, Michael P.

AU - DeMartino, Julie A.

AU - Kabat, David

PY - 1999/1/22

Y1 - 1999/1/22

N2 - Like the CCR5 chemokine receptors of humans and rhesus macaques, the very homologous (~98-99% identical) CCR5 of African green monkeys (AGMs) avidly binds β-chemokines and functions as a coreceptor for simian immunodeficiency viruses. However, AGM CCR5 is a weak coreceptor for tested macrophage-tropic (R5) isolates of human immunodeficiency virus type 1 (HIV- 1). Correspondingly, gp120 envelope glycoproteins derived from R5 isolates of HIV-1 bind poorly to AGM CCR5. We focused on a unique extracellular amino acid substitution at the juncture of transmembrane helix 4 (TM4) and extracellular loop 2 (ECL2) (Arg for Gly at amino acid 163 (G163R)) as the likely source of the weak R5 gp120 binding and HIV-1 coreceptor properties of AGM CCRS. Accordingly, a G163R mutant of human CCR5 was severely attenuated in its ability to bind R5 gp120s and to mediate infection by R5 HIV-1 isolates. Conversely, the R163G mutant of AGM CCR5 was substantially strengthened as a coreceptor for HIV-1 and had improved R5 gp120 binding affinity relative to the wild-type AGM CCR5. These substitutions at amino acid position 163 had no effect on chemokine binding or signal transduction, suggesting the absence of structural alterations. The 2D7 monoclonal antibody has been reported to bind to ECL2 and to block HIV-1 binding and infection. Whereas 2D7 antibody binding to CCR5 was unaffected by the G163R mutation, it was prevented by a conservative ECL2 substitution (K171R), shared between rhesus and AGM CCR5s. Thus, it appears that the 2D7 antibody binds to an epitope that includes Lys-171 and may block HIV-1 infection mediated by CCR5 by occluding an HIV-1-binding site in the vicinity of Gly163. In summary, our results identify a site for gp120 interaction that is critical for R5 isolates of HIV-1 in the central core of human CCR5, and we propose that this site collaborates with a previously identified region in the CCR5 amino terminus to enable gp120 binding and HIV-1 infections.

AB - Like the CCR5 chemokine receptors of humans and rhesus macaques, the very homologous (~98-99% identical) CCR5 of African green monkeys (AGMs) avidly binds β-chemokines and functions as a coreceptor for simian immunodeficiency viruses. However, AGM CCR5 is a weak coreceptor for tested macrophage-tropic (R5) isolates of human immunodeficiency virus type 1 (HIV- 1). Correspondingly, gp120 envelope glycoproteins derived from R5 isolates of HIV-1 bind poorly to AGM CCR5. We focused on a unique extracellular amino acid substitution at the juncture of transmembrane helix 4 (TM4) and extracellular loop 2 (ECL2) (Arg for Gly at amino acid 163 (G163R)) as the likely source of the weak R5 gp120 binding and HIV-1 coreceptor properties of AGM CCRS. Accordingly, a G163R mutant of human CCR5 was severely attenuated in its ability to bind R5 gp120s and to mediate infection by R5 HIV-1 isolates. Conversely, the R163G mutant of AGM CCR5 was substantially strengthened as a coreceptor for HIV-1 and had improved R5 gp120 binding affinity relative to the wild-type AGM CCR5. These substitutions at amino acid position 163 had no effect on chemokine binding or signal transduction, suggesting the absence of structural alterations. The 2D7 monoclonal antibody has been reported to bind to ECL2 and to block HIV-1 binding and infection. Whereas 2D7 antibody binding to CCR5 was unaffected by the G163R mutation, it was prevented by a conservative ECL2 substitution (K171R), shared between rhesus and AGM CCR5s. Thus, it appears that the 2D7 antibody binds to an epitope that includes Lys-171 and may block HIV-1 infection mediated by CCR5 by occluding an HIV-1-binding site in the vicinity of Gly163. In summary, our results identify a site for gp120 interaction that is critical for R5 isolates of HIV-1 in the central core of human CCR5, and we propose that this site collaborates with a previously identified region in the CCR5 amino terminus to enable gp120 binding and HIV-1 infections.

UR - http://www.scopus.com/inward/record.url?scp=0033593324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033593324&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.4.1905

DO - 10.1074/jbc.274.4.1905

M3 - Article

C2 - 9890944

AN - SCOPUS:0033593324

VL - 274

SP - 1905

EP - 1913

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 4

ER -